OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results
Stephen V. Liu, Rafał Dziadziuszko, Shunichi Sugawara, Steven Kao, Maximilian J. Hochmair, Florian Huemer, Gilberto de Castro, Libor Havel, R.B. Caro, G Losonczy, J.-S. Lee, D. Kowalski, Zoran Andrić, Raffaele Califano, Andrea Veatch, Gregory J. Gerstner, Marta Batus, S. Morris, Manika Kaul, M. Siddiqui, H. Li, W. Zhang, Barzin Y. Nabet, Martin Reck
Topics & Concepts
AtezolizumabMedicineCarboplatinEtoposideInternal medicinePlaceboOncologyChemotherapyImmunotherapyCisplatinCancerPembrolizumabPathologyAlternative medicineLung Cancer Research StudiesPancreatic and Hepatic Oncology ResearchNeutropenia and Cancer Infections